The U.S. drugmaker expects its annual revenue to be in the range of $58.5 billion to $61.5 billion compared with analysts' average estimate of $63.07 billion.
(Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)
Market Closed -
Other stock markets
|
After market 08:00:00 pm | |||
28.82 USD | +1.55% | 28.84 | +0.07% |
11:56am | Pfizer Offers to Settle Zantac Claims for Up to $250 Million | MT |
07:41am | Basilea Pharmaceutica Receives Milestone Payment from Pfizer for Cresemba Sales | MT |
(Reuters) - Pfizer on Wednesday forecast 2024 revenue that was below Wall Street expectations, and increased its target for cost cuts by $500 million.
The U.S. drugmaker expects its annual revenue to be in the range of $58.5 billion to $61.5 billion compared with analysts' average estimate of $63.07 billion.
(Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)
1st Jan change | Capi. | |
---|---|---|
+0.10% | 163B | |
+35.01% | 709B | |
+30.43% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.42% | 239B | |
+9.46% | 211B | |
-3.68% | 203B | |
+10.77% | 171B |